Clinical trial
Efficacy and Safety of Vaccination Against Influenza H1N1 in Patients With Rheumatoid Arthritis, Systemic Lupus Erythematosus, Psoriatic Arthritis and Ankylosing Spondylitis Treated With Immunomodulatory Drugs
NCT01006681 is registered in ClinicalTrials.gov with Tel-Aviv Sourasky Medical Center as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Efficacy and Safety of Vaccination Against Influenza H1N1 in Patients With Rheumatoid Arthritis, Systemic Lupus Erythematosus, Psoriatic Arthritis and Ankylosing Spondylitis Treated With Immunomodulatory Drugs
- Lead sponsor
- Tel-Aviv Sourasky Medical Center
- Phase
- Phase 2
- Overall status
- Unknown status
- Start date
- November 30, 2009
- Completion date
- April 30, 2010
- Enrollment
- 400 (estimated)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.
influenza, rheumatic diseases